LawCash Links

Recommended

After the Anthrax attacks in 2001, the antibiotic Cipro was widely hailed as the preferred treatment for those who thought they had been exposed to the disease. A class action has been filed against German drug manufacturer Bayer AG on behalf of employees of the Brentwood Post Office in Washington, D.C., and workers at the U.S. Capitol, along with employees of American Media, Inc. in Florida and postal workers in general, all of whom allege that they have suffered serious side effects from taking the antibiotic ciprofloxacin (Cipro) in the aftermath of the anthrax attacks in 2001. The action alleges that Bayer failed to warn them of the potential side effects in violation of the Pennsylvania Unfair Trade Practices and Consumer Protection Laws.

Kahn Gauthier Swick is investigating possible legal actions against Cordis Corporation on behalf of persons who have been injured by the company's Cypher coronary stent. On October 29, 2003, the federal Food and Drug Administration issued a warning that a significant number of adverse effects had been reported since the Cypher stent was approved on April 24. Both blood clotting and hypersensitivity reactions have been reported.

Kahn Gauthier Swick is investigating possible legal actions against nursing homes to recover for injuries suffered by nursing home residents. There are more than one and one-half million elderly and disabled persons in 17,000 nursing homes across the United States.

Corporate giants Pfizer and Microsoft have separately filed lawsuits against the operators of two web sites that send spam e-mails with offers for allegedly illegal generic versions of the erectile dysfunction medication Viagra . Both lawsuits accuse www.cndpharmacy.com and www.myepharmacydirect.com of violation of the company trademark and unfair competition.

A company is caught engaging in anticompetitive behavior, either state or federal antitrust law may be used against it. A class action has been filed against Medco Health Solutions, Inc. and Merck & Company on behalf of California pharmacists, who allege that the companies engaged in anticompetitive behavior in violation of state antitrust law.

In this day of incurable transmissible diseases, it would be nice to be confident that the needle that gets stuck in your arm has never been used before. On November 5, 2003, the court granted preliminary approval to the parties' $25 million proposed settlement in a class action filed against Oklahoma's Norman Regional Hospital, a clinic administrator, and nurse anesthetist James Hill who is accused of reusing needles when administering intravenous pain medicine to patients in the hospital's clinic in violation of state medical regulations.

IT'S FREE